tiprankstipranks
Trending News
More News >
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market

Barinthus Biotherapeutics (BRNS) Income Statement

Compare
108 Followers

Barinthus Biotherapeutics Income Statement

Last quarter (Q4 2025), Barinthus Biotherapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Barinthus Biotherapeutics's net income was $-11.09M. See Barinthus Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 14.97M$ 802.00K$ 44.70M$ 268.00K
Gross Profit
$ -5.86M$ 14.97M$ 802.00K$ 44.70M$ 268.00K
Operating Expenses
$ 48.34M$ 82.94M$ 84.72M$ 48.74M$ 45.49M
Depreciation and Amortization
$ 5.84M$ 5.80M$ 5.43M$ 4.32M$ 602.00K
EBITDA
$ -48.34M$ -55.37M$ -71.06M$ 5.19M$ -47.87M
Operating Income
$ -54.19M$ -67.97M$ -83.91M$ -4.04M$ -45.22M
Other Income/Expenses
$ -14.60M$ 6.74M$ 7.39M$ 4.89M$ -5.92M
Pretax Income
$ -68.79M$ -61.23M$ -76.52M$ 850.00K$ -51.14M
Net Income
$ -66.43M$ -61.07M$ -73.35M$ 5.34M$ -50.87M
Per Share Metrics
Basic EPS
$ -1.64$ -1.55$ -1.91$ 0.14$ -1.37
Diluted EPS
$ -1.64$ -1.55$ -1.91$ 0.14$ -1.37
Weighted Average Shares Outstanding
40.53M 39.35M 38.39M 37.25M 37.19M
Weighted Average Shares Outstanding (Diluted)
40.53M 39.35M 38.39M 38.17M 37.19M
Currency in USD

Barinthus Biotherapeutics Earnings and Revenue History